v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue:    
Total revenue $ 9,216,000 $ 9,182,000
Cost of revenue:    
Total cost of revenue 3,301,000 3,703,000
Gross profit 5,915,000 5,479,000
Operating expenses:    
Research and development 2,878,000 3,266,000
Sales and marketing 2,986,000 8,146,000
General and administrative 7,964,000 10,345,000
Total operating expenses 13,828,000 21,757,000
Loss from operations (7,913,000) (16,278,000)
Other (expense) income, net:    
Change in fair value of warrant liabilities (5,607,000) 1,346,000
Change in fair value of convertible notes 170,000  
Loss upon issuance of convertible notes carried at fair value (1,198,000)  
Interest expense, net (41,000) (33,000)
Other income (expense), net 1,809,000 1,871,000
Total other (expense) income, net (4,867,000) 3,184,000
Net loss $ (12,780,000) $ (13,094,000)
Net loss per share - basic (in dollars per share) $ (0.37) $ (0.93)
Net loss per share - diluted (in dollars per share) $ (0.37) $ (0.93)
Weighted average common shares used to compute basic net loss per common share (in shares) 34,102,760 14,134,626
Weighted average common shares used to compute diluted net loss per common share (in shares) 34,102,760 14,134,626
Product    
Revenue:    
Total revenue $ 9,216,000 $ 9,182,000
Cost of revenue:    
Total cost of revenue $ 3,301,000 $ 3,703,000